313 related articles for article (PubMed ID: 25582745)
1. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
Araujo RL; Gönen M; Allen P; DeMatteo R; Kingham P; Jarnagin W; D'Angelica M; Fong Y
Ann Surg Oncol; 2015 Sep; 22(9):3087-93. PubMed ID: 25582745
[TBL] [Abstract][Full Text] [Related]
2. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
6. Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis.
Bredt LC; Rachid AF
World J Surg Oncol; 2014 Dec; 12():391. PubMed ID: 25528650
[TBL] [Abstract][Full Text] [Related]
7. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
Hohenberger P; Schlag PM; Gerneth T; Herfarth C
Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
[TBL] [Abstract][Full Text] [Related]
8. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
11. recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival.
Hill CR; Chagpar RB; Callender GG; Brown RE; Gilbert JE; Martin RC; McMasters KM; Scoggins CR
Ann Surg Oncol; 2012 Jan; 19(1):139-44. PubMed ID: 21751045
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases.
Gervaz P; Blanchard A; Pampallona S; Mach JP; Fontolliet C; Gillet M
Eur J Surg; 2000 Jul; 166(7):557-61. PubMed ID: 10965835
[TBL] [Abstract][Full Text] [Related]
13. Recurrence after complete cryoablation of colorectal liver metastases: analysis of prognostic features.
Yan TD; Nunn DR; Morris DL
Am Surg; 2006 May; 72(5):382-90. PubMed ID: 16719189
[TBL] [Abstract][Full Text] [Related]
14. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
15. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome after repeat resection for colorectal liver metastases.
Saiura A; Yamamoto J; Koga R; Takahashi Y; Takahashi M; Inoue Y; Ono Y; Kokudo N
Ann Surg Oncol; 2014 Dec; 21(13):4293-9. PubMed ID: 24962942
[TBL] [Abstract][Full Text] [Related]
17. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
[TBL] [Abstract][Full Text] [Related]
19. Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
Yoshino K; Osumi H; Ito H; Kamiimabeppu D; Ooki A; Wakatsuki T; Shimozaki K; Nakayama I; Ogura M; Takahari D; Chin K; Oba A; Ono Y; Sato T; Inoue Y; Takahashi Y; Yamaguchi K; Shinozaki E
Ann Surg Oncol; 2022 Dec; 29(13):8385-8393. PubMed ID: 35974233
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
